Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists

Clinical trial NCT07224880 · RECRUITING

Trial details

NCT number: NCT07224880
Sponsor: Cytrellis Biosystems, Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

glp1 Agonist Gene Expression Skin Laxity

Start date: 2025-10-14
Primary completion: 2026-01-30
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.